Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Basic Research in Cardiology|April 14, 2016
Mild endothelial dysfunction in Sirt3 knockout mice fed a high-cholesterol diet: protective role of a novel C/EBP-β-dependent feedback regulation of SOD2Stephan Winnik, Daniel S Gaul, Giovanni Siciliani, et al.
American Heart Journal|August 10, 2010
Predictors of early readmission or death in elderly patients with heart failureStefano Muzzarelli, Gregor Leibundgut, Micha T Maeder, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 24, 2018
Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodellingKatja E Odening, Sebastian Deiß, Dagmara Dilling-Boer, et al.
Circulation Research|September 19, 2009
Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathyPrzemyslaw Blyszczuk, Gabriela Kania, Thomas Dieterle, et al.
European Heart Journal|December 14, 2004
Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME)Jacques Claude, Christian Schindler, Gabriela M Kuster, et al.
European Heart Journal|January 17, 2013
Mononuclear cell secretome protects from experimental autoimmune myocarditisKonrad Hoetzenecker, Matthias Zimmermann, Wolfram Hoetzenecker, et al.
European Heart Journal|June 12, 2004
Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trialChristoph Kaiser, Gabriela M Kuster, Paul Erne, et al.
JAMA|March 8, 2003
Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trialMatthias Pfisterer, Peter Buser, Stefan Osswald, et al.
Circulation|September 10, 2003
Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failureGavin Y Oudit, Michael A Crackower, Urs Eriksson, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 12, 2024
Challenges and pitfalls during CRT implantation in patients with persistent left superior vena cavaDeniz Akdis, Julia Vogler, Malte-Maria Sieren, et al.
Pageof 14